These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24935619)

  • 21. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.
    Parkinson Study Group
    N Engl J Med; 1993 Jan; 328(3):176-83. PubMed ID: 8417384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian latent time joint mixed effect models for multicohort longitudinal data.
    Li D; Iddi S; Thompson WK; Donohue MC;
    Stat Methods Med Res; 2019 Mar; 28(3):835-845. PubMed ID: 29168432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. The Parkinson Study Group.
    Shoulson I
    Eur Neurol; 1992; 32 Suppl 1():46-53. PubMed ID: 1425820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multilevel joint model of longitudinal continuous and binary outcomes for hierarchically structured data.
    Zhou GC; Song S; Szczesniak RD
    Stat Med; 2023 Jul; 42(17):2914-2927. PubMed ID: 37170074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group.
    Kieburtz K; McDermott M; Como P; Growdon J; Brady J; Carter J; Huber S; Kanigan B; Landow E; Rudolph A
    Neurology; 1994 Sep; 44(9):1756-9. PubMed ID: 7936311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.
    Ward CD
    J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):217-20. PubMed ID: 8126510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Joint modeling of multiple repeated measures and survival data using multidimensional latent trait linear mixed model.
    Wang J; Luo S
    Stat Methods Med Res; 2019; 28(10-11):3392-3403. PubMed ID: 30306833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian variable selection and estimation in semiparametric joint models of multivariate longitudinal and survival data.
    Tang AM; Zhao X; Tang NS
    Biom J; 2017 Jan; 59(1):57-78. PubMed ID: 27667731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective clinical strategies for Parkinson's disease.
    Shoulson I
    Ann Neurol; 1992; 32 Suppl():S143-5. PubMed ID: 1510374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.
    Coull BA; Bobb JF; Wellenius GA; Kioumourtzoglou MA; Mittleman MA; Koutrakis P; Godleski JJ
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):5-50. PubMed ID: 26333238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joint analysis of stochastic processes with application to smoking patterns and insomnia.
    Luo S
    Stat Med; 2013 Dec; 32(29):5133-44. PubMed ID: 23913574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R-(-)-deprenyl as a possible protective agent in Parkinson's disease.
    Tetrud JW; Langston JW
    J Neural Transm Suppl; 1987; 25():69-79. PubMed ID: 3123606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented Beta rectangular regression models: A Bayesian perspective.
    Wang J; Luo S
    Biom J; 2016 Jan; 58(1):206-21. PubMed ID: 26289406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group.
    Ann Neurol; 1998 Mar; 43(3):318-25. PubMed ID: 9506548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal measurement in health-related surveys. A Bayesian joint growth model for multivariate ordinal responses.
    Verhagen J; Fox JP
    Stat Med; 2013 Jul; 32(17):2988-3005. PubMed ID: 23212734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Bayesian semiparametric joint hierarchical model for longitudinal and survival data.
    Brown ER; Ibrahim JG
    Biometrics; 2003 Jun; 59(2):221-8. PubMed ID: 12926706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using an empirical binomial hierarchical Bayesian model as an alternative to analyzing data from multisite studies.
    Hardin JM; Anderson BS; Woodby LL; Crawford MA; Russell TV
    Eval Rev; 2008 Apr; 32(2):143-56. PubMed ID: 18319422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semiparametric Bayesian inference on skew-normal joint modeling of multivariate longitudinal and survival data.
    Tang AM; Tang NS
    Stat Med; 2015 Feb; 34(5):824-43. PubMed ID: 25404574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease.
    Tetrud JW; Langston JW
    Science; 1989 Aug; 245(4917):519-22. PubMed ID: 2502843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Parkinson Study Group.
    Arch Neurol; 1995 Mar; 52(3):237-45. PubMed ID: 7872875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.